Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.84 HKD | +4.67% | +7.17% | +35.54% |
May. 22 | Henlius Biotech Gets China Approval for New Indications of Arthritis Drug | MT |
May. 22 | Henlius Biotech Amends License Deals with Palleon for Bifunctional Protein Products | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.54% | 1.25B | |
-1.86% | 89.49B | |
+2.24% | 40.67B | |
-12.97% | 33.15B | |
+61.72% | 26.45B | |
-20.71% | 14.69B | |
-7.31% | 12.89B | |
-12.64% | 11.54B | |
-42.60% | 11.34B | |
+4.27% | 8.84B |
- Stock Market
- Equities
- 2696 Stock
- News Shanghai Henlius Biotech, Inc.
- Henlius Biotech Gets Clearance for China Clinical Trial of Carcinoma Drug